This Article Full Text Full Text (PDF) All Versions of this Article: 23/7/1302    most recent 01.ATV.0000079510.23517.43v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ulrichts, H. Articles by Deckmyn, H. Search for Related Content PubMed PubMed Citation Articles by Ulrichts, H. Articles by Deckmyn, H. Related Collections Pediatric and congenital heart disease, including cardiovascular surgery Smooth muscle proliferation and differentiation

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1302.)
© 2003 American Heart Association, Inc.

Thrombosis

Von Willebrand Factor But Not -Thrombin Binding to Platelet Glycoprotein Ib Is Influenced by the HPA-2 Polymorphism

Hans Ulrichts; Karen Vanhoorelbeke; Sandra Cauwenberghs; Stephan Vauterin; Hartmut Kroll; Sentot Santoso; Hans Deckmyn

From the Laboratory for Thrombosis Research, IRC, KULeuven Campus Kortrijk, Belgium and Institute for Clinical Immunology and Transfusion Medicine (H.K., S.S.), Justus Liebig University, Giessen, Germany.

Correspondence to Dr Hans Deckmyn, Laboratory for Thrombosis Research, IRC, KULeuven Campus Kortrijk, E. Sabbelaan 53, 8500 Kortrijk, Belgium. E-mail Hans.Deckmyn{at}kulak.ac.be

Objective— Glycoprotein (GP) Ib is the functionally dominant subunit of the platelet GPIb-IX-V receptor complex. The N-terminal domain of the GPIb chain contains binding sites for -thrombin and von Willebrand factor (VWF). The human platelet alloantigen (HPA)-2 polymorphism of the GPIb gene is associated with a C/T transition at nucleotide 1018, resulting in a Thr/Met dimorphism at residue 145 of GPIb. To study the structural and functional effects of this dimorphism, N-terminal fragments (AA1-289) of the HPA-2a and HPA-2b alloform of GPIb expressed in CHO cells were used.

Methods and Results— Of 74 moAbs directed against human GPIb, 2 antibodies with epitope between AA1-59 could differentiate between both alloforms. In addition, VWF bound with a higher affinity to the recombinant HPA-2a fragment or to homozygous HPA-2a platelets. In contrast, no difference was found in the binding of -thrombin to the recombinant alloform fragments or of antibodies directed against the -thrombin binding anionic sulfated tyrosine sequence (AA269-282).

Conclusions— Whereas the Thr145Met dimorphism does not affect -thrombin binding, it does influence the conformation of the N-terminal flanking region and first leucine-rich repeat of GPIb and by this has an effect on VWF binding.

Key Words: glycoprotein Ib • Willebrand • HPA-2 polymorphism • thrombin

This article has been cited by other articles:

				J. P. Corsetti, D. Ryan, A. J. Moss, D. L. Rainwater, W. Zareba, and C. E. Sparks Glycoprotein Ib{alpha} Polymorphism T145M, Elevated Lipoprotein-Associated Phospholipase A2, and Hypertriglyceridemia Predict Risk for Recurrent Coronary Events in Diabetic Postinfarction Patients Diabetes, May 1, 2007; 56(5): 1429 - 1435. [Abstract] [Full Text] [PDF]

				S. F. De Meyer, K. Vanhoorelbeke, M. K. Chuah, I. Pareyn, V. Gillijns, R. P. Hebbel, D. Collen, H. Deckmyn, and T. VandenDriessche Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor Blood, June 15, 2006; 107(12): 4728 - 4736. [Abstract] [Full Text] [PDF]

				K. V. Vijayan and P. F. Bray Molecular Mechanisms of Prothrombotic Risk Due to Genetic Variations in Platelet Genes: Enhanced Outside-In Signaling Through the Pro33 Variant of Integrin {beta}3. Experimental Biology and Medicine, May 1, 2006; 231(5): 505 - 513. [Abstract] [Full Text] [PDF]

				H. Ulrichts, M. Udvardy, P. J. Lenting, I. Pareyn, N. Vandeputte, K. Vanhoorelbeke, and H. Deckmyn Shielding of the A1 Domain by the D'D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V J. Biol. Chem., February 24, 2006; 281(8): 4699 - 4707. [Abstract] [Full Text] [PDF]

				J. Mikkelsson, M. Perola, and P. J. Karhunen Genetics of Platelet Glycoprotein Receptors: Risk of Thrombotic Events and Pharmacogenetic Implications Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 113 - 125. [Abstract] [PDF]

				J. A. Iniesta, R. Gonzalez-Conejero, C. Piqueras, V. Vicente, and J. Corral Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage Stroke, October 1, 2004; 35(10): 2282 - 2286. [Abstract] [Full Text] [PDF]